Brazilian Life Sciences Database

- Today, two manuscripts published back to back detail the full results from the BE RADIANT and BE SURE studies, comparing the efficacy and safety of bimekizumab to secukinumab and adalimumab, respectively;- Results from BE RADIANT were also shared today as a late-breaking oral presentation at AAD... Read more ››

By: PR Newswire Association LLC. - 23 Apr 2021

Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide

By: GlobenewsWire - 21 Apr 2021

PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC

By: PR Newswire Association LLC. - 19 Apr 2021

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 19 Apr 2021

European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma

By: GlobenewsWire - 19 Apr 2021

1 2 3 4 5 6 »

Looking for companies outside of Brazil?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

May 2021
- Biotechgate Digital Partnering
- Shanghai: ChinaBio® Partnering Forum
- European Health-tech Innovation Week

See Events »

Add an Event »

Latest company news

Novo Nordisk A/S purchases B shares worth DKK 2,586 million from Novo Holdings A/S under the 2021 share repurchase programme
07 May 2021 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
07 May 2021 (GlobenewsWire)

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2021
07 May 2021 (GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Brazil?

Partners

Upcoming Life Sciences Events

Latest company news